Suppression of Tescalcin inhibits growth and metastasis in renal cell carcinoma via downregulating NHE1 and NF-kB signaling.
CONCLUSIONS: These findings demonstrate that atopic expression of Tescalcin facilitates the survival, migration and invasion of RCC cells via NHE1/pHi axis as well as AKT/ NF-κB signaling pathway, providing new perspectives for the future study of Tescalcin as a therapeutic target for RCC.
PMID: 30594602 [PubMed - as supplied by publisher]
Source: Experimental and Molecular Pathology - Category: Pathology Authors: Luo AJ, Tan J, He LY, Jiang XZ, Jiang ZQ, Zeng Q, Yao K, Xue J Tags: Exp Mol Pathol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Molecular Biology | Pathology | Renal Cell Carcinoma | Study | Urology & Nephrology